Chemiluminescence immunoassay for measuring high-sensitivity cardiac troponin I, used for acute myocardial infarction detection and diagnosis.
Manufactured by
Suzhou Hokapi Biomedical Engineering Co., Ltd.
China
Suzhou Hokapi Biomedical Engineering Co., Ltd is a high-tech enterprise focused on R&D, production and marketing of automated CLIA system and automatic blood grouping system. In November 2018, bioMérieux acquired a majority shareholding in Hokapi. So far we have 100 parameters for CLIA system. Our systems are widely recognized for their reliability and precision in clinical laboratory diagnostics.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Indo MIM Limited
India · 1 relevant product
HeavyBio, Inc
China · 8 relevant products
Shenzhen Kingfocus Biomedical Engineering Co., Ltd.
China · 2 relevant products
79 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 117 closest product alternatives
Indo MIM Limited · India
An assay for detection of high-sensitivity cardiac troponin I enabling early detection of myocardial injury. Facilitates accurate and timely diagnosis of acute cardiac events.
HeavyBio, Inc · China
Advanced immunoassay with enhanced sensitivity for detecting low levels of cardiac troponin in blood. Enables earlier diagnosis of myocardial infarction and improved patient risk stratification.
Shenzhen Kingfocus Biomedical Engineering Co., Ltd. · China
Ultra-sensitive cardiac troponin I immunoassay achieving detection limit of 0.005ng/mL for acute myocardial infarction diagnosis. Enables early cardiac injury detection with superior clinical sensitivity.
114 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products